Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Ferrarotti, T.P. Carroll, S. Inghilleri, S. Ottaviani, M. Luisetti, N.G. McElvaney (Pavia, Italy; Dublin, Ireland). Effect of augmentation therapy on immune function of patients with severe Alpha1-antitrypsin deficiency. Eur Respir J 2012; 40: Suppl. 56, 2119

Member's Comments

No comment yet.

Related content which might interest you: The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Efficacy of augmentation therapy for emphysema associated with alpha1-antitrypsin deficiency: enough is enough Source: Eur Respir J 2016; 47: 35-38 Year: 2016 Effect of intravenous alpha-1-antitrypsin augmentation therapy on proteinase-3-generated AaVal541 in deficient patients Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Long-term effect of alpha-1-antitrypsin augmentation therapy on the decline of FEV1 in deficient patients Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021 Impact of alpha 1-antitrypsin deficiency and prior augmentation therapy on patients' survival after lung transplantation Source: Eur Respir J, 50 (3) 1700962; 10.1183/13993003.00962-2017 Year: 2017 Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease. Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Effect of enzyme replacement therapy (ERT) on lung involvement and changes of different peripheral blood T-cell subsets in Fabry disease patients Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Immunoglobulin treatment with recommended dosages do not prevent deterioration in lung function in primary hypogammaglobulinemia Source: Eur Respir J 2006; 28: Suppl. 50, 557s Year: 2006 Effect of 2-Year therapy with Roflumilast in severe systemic inflammation in COPD with metabolic syndrome Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 Intravenous α1-antitrypsin in a child with deficiency and severe lung disease Source: Eur Respir J 2009; 34: 278-279 Year: 2009 Pulmonary administration of alpha1-antitrypsin for the treatment of Alpha1-antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 385s Year: 2003 Alterations of lung function in children with juvenile idiopathic arthritis under therapy Source: Eur Respir J 2002; 20: Suppl. 38, 139s Year: 2002 Current and future therapy of lung emphysema caused by alpha-1-antitrypsin deficiency Source: Annual Congress 2004 - Alpha-1-antitrypsin deficiency: Current knowledge and new frontiers Year: 2004 Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002 Severe asthma in old patients is characterized by signs of immunosuppression and by lymphocyte resistance to glucocorticoids Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012 The effect of androgen replacement treatment on pulmonary functions in male patients with hypogonadism Source: Eur Respir J 2006; 28: Suppl. 50, 862s Year: 2006 Reversibility of diffusion capacity abnormalities in patients with clinical hypothyroidism with establishment of euthyroid state Source: Annual Congress 2013 –New issues in lung function testing Year: 2013 Influence of N-acetylcystein in complex basic therapy on the dynamics of pulmonary function test indices in severe bronchial asthma patients Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 The withdrawal of replacement therapy and outcomes in alpha-1 antitrypsin deficiency lung transplant recipients Source: Eur Respir J, 53 (5) 1900055; 10.1183/13993003.00055-2019 Year: 2019